Search

everythinglearnresearchcommunity

for

Search:↓

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

EGF controls hair growth by regulating hair follicles' growth phases.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Skin-derived precursors in hair follicles come from different origins but function similarly.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Minoxidil can reduce functions related to androgen receptors.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Androgens may block hair growth signals, targeting this could treat hair loss.

Biotin helps regulate proteins in the blood, which may explain its role in hair growth.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

A specific RNA molecule, circCOL1A1, affects the growth and quality of goat hair by interacting with miR-149-5p and influencing cell growth pathways.

Cosmetics with hinokitiol-loaded nanocapsules were found to effectively promote hair growth.

Nanoparticles show potential for controlled release of hair loss drugs, improving treatment effectiveness.

PCOS affects many women and requires early detection and symptom management.

Married women with type 2 diabetes had a surprisingly low infertility rate, suggesting type 2 diabetes and PCOS may be different conditions.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Minoxidil can be effectively encapsulated in coated nanovesicles for potential drug delivery.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Mice with human gene experienced hair loss when treated with DHT.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Finasteride side effects in young men may be linked to specific gene variations.

Dutasteride and finasteride affect different cell types differently.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.